AnnouncementsBreckenridge/NATCO files ANDA for Everolimus
No recommendations so far.What's your call on Natco Pharma today?
|Company Name||Last Price||%
|Dr Reddys Labs||3208.30||-0.12||3252.00||2420.00||54,658.47|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
Natco Pharma Recommended on Aug 14th 2014
Recommended price 1,083.00 | Peak from reco 1585.70 46.42%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Natco Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 5,045.63 crore.The company has reported a consolidated sales of Rs 190.48 crore and a Net Profit of Rs 32.21 crore for the quarter ended Jun 2014.
The company management includes V C Nannapaneni - Chairman & Managing Director, Rajeev Nannapaneni - Vice Chairman & CEO, T V Rao - Nominee Director, G S Murthy - Director, B S Bajaj - Director, P Bhaskara Narayana - Director & CFO, A K S Bhujanga Rao - President & Director, Vivek Chhacchi - Additional Director, D G Prasad - Additional Director.
It is listed on the BSE with a BSE Code of 524816 and the NSE with an NSE Code of NATCOPHARM.
Its Registered office is at NATCO House, Road No.2,,Banjara Hills Hyderabad,Telangana - 500034.
Their Registrars are Venture Capital & Corporate Investments Pvt. Ltd.